Daunorubicin induced Stevens‐Johnson syndrome: A case report

Clinicians should consider the possible association of Daunorubicin with Stevens‐Johnson syndrome (SJS), administer it with caution and promptly evaluate all subsequently developing cutaneous reactions with a high index of suspicion for Stevens‐Johnson syndrome.

Detalles Bibliográficos
Autores principales: Shakya, Preeti, Sharma Nepal, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283860/
https://www.ncbi.nlm.nih.gov/pubmed/34295492
http://dx.doi.org/10.1002/ccr3.4475
Descripción
Sumario:Clinicians should consider the possible association of Daunorubicin with Stevens‐Johnson syndrome (SJS), administer it with caution and promptly evaluate all subsequently developing cutaneous reactions with a high index of suspicion for Stevens‐Johnson syndrome.

Ejemplares similares